Hungarian Brain Research Program(NAP2022-I-1/2022)
János Bolyai Research Scholarship of the Hungarian Academy of Sciences(BO/00469/23/5)
(LP2022‐5/2022) Támogató: Hungarian Academy of Sciences
NAP2022-I-1/2022(Hungarian Brain Research Program)
(ÚNKP‐22‐4‐I‐SE‐1) Támogató: ÚNKP
(ÚNKP‐23‐4‐II‐SE‐16) Támogató: ÚNKP
(NAP2022-I-1/2022)
Szakterületek:
Tudomány
Cerebral ischemia is a devastating condition that results in impaired blood flow in
the brain leading to acute brain injury. As the most common form of stroke, occlusion
of cerebral arteries leads to a characteristic sequence of pathophysiological changes
in the brain tissue. The mechanisms involved, and comorbidities that determine outcome
after an ischemic event appear to be highly heterogeneous. On their own, the processes
leading to neuronal injury in the absence of sufficient blood supply to meet the metabolic
demand of the cells are complex and manifest at different temporal and spatial scales.
While the contribution of non‐neuronal cells to stroke pathophysiology is increasingly
recognized, recent data show that microglia, the main immune cells of the central
nervous system parenchyma, play previously unrecognized roles in basic physiological
processes beyond their inflammatory functions, which markedly change during ischemic
conditions. In this review, we aim to discuss some of the known microglia–neuron–vascular
interactions assumed to contribute to the acute and delayed pathologies after cerebral
ischemia. Because the mechanisms of neuronal injury have been extensively discussed
in several excellent previous reviews, here we focus on some recently explored pathways
that may directly or indirectly shape neuronal injury through microglia‐related actions.
These discoveries suggest that modulating gliovascular processes in different forms
of stroke and other neurological disorders might have presently unexplored therapeutic
potential in combination with neuroprotective and flow restoration strategies.